xpf1utml

Property	Value
?:abstract	BACKGROUND: Human umbilical cord mesenchymal stem cells (HUC-MSCs) present in the umbilical cord tissue are self-renewing and multipotent. They can renew themselves continuously and, under certain conditions, differentiate into one or more cell types constituting human tissues and organs. HUC-MSCs differentiate, among others, into osteoblasts, chondrocytes, and adipocytes and have the ability to secrete cytokines. The possibility of noninvasive harvesting and low immunogenicity of HUC-MSCs give them a unique advantage in clinical applications. In recent years, HUC-MSCs have been widely used in clinical practice, and some progress has been made in their use for therapeutic purposes. MAIN BODY: This article describes two aspects of the clinical therapeutic effects of HUC-MSCs. On the one hand, it explains the benefits and mechanisms of HUC-MSC treatment in various diseases. On the other hand, it summarizes the results of basic research on HUC-MSCs related to clinical applications. The first part of this review highlights several functions of HUC-MSCs that are critical for their therapeutic properties: differentiation into terminal cells, immune regulation, paracrine effects, anti-inflammatory effects, anti-fibrotic effects, and regulating non-coding RNA. These characteristics of HUC-MSCs are discussed in the context of diabetes and its complications, liver disease, systemic lupus erythematosus, arthritis, brain injury and cerebrovascular diseases, heart diseases, spinal cord injury, respiratory diseases, viral infections, and other diseases. The second part emphasizes the need to establish an HUC-MSC cell bank, discusses tumorigenicity of HUC-MSCs and the characteristics of different in vitro generations of these cells in the treatment of diseases, and provides technical and theoretical support for the clinical applications of HUC-MSCs. CONCLUSION: HUC-MSCs can treat a variety of diseases clinically and have achieved good therapeutic effects, and the development of HUC-MSC assistive technology has laid the foundation for its clinical application.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/xpf1utml_hasAnnotation_C0009566> <https://research.tib.eu/covid-19/entity/xpf1utml_hasAnnotation_C0037929> <https://research.tib.eu/covid-19/entity/xpf1utml_hasAnnotation_C0270611> <https://research.tib.eu/covid-19/entity/xpf1utml_hasAnnotation_C0887909> <https://research.tib.eu/covid-19/entity/xpf1utml_hasAnnotation_C1414373> <https://research.tib.eu/covid-19/entity/xpf1utml_hasAnnotation_C1519697> <https://research.tib.eu/covid-19/entity/xpf1utml_hasAnnotation_C1825598> <https://research.tib.eu/covid-19/entity/xpf1utml_hasAnnotation_C3539125>
?:creator	<https://research.tib.eu/covid-19/entity/Xie%2C_Qixin%3B_Liu%2C_Rui%3B_Jiang%2C_Jia%3B_Peng%2C_Jing%3B_Yang%2C_Chunyan%3B_Zhang%2C_Wen%3B_Wang%2C_Sheng%3B_Song%2C_Jing>
?:doi	<https://research.tib.eu/covid-19/entity/10.1186/s13287-020-02011-z>
?:doi	10.1186/s13287-020-02011-z
?:journal	Stem_Cell_Res_Ther
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/f0919bb8c45a03043d9596e20743712c5ed836dc.json
?:pmc_json_files	document_parses/pmc_json/PMC7705855.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7705855>
?:pmid	<https://research.tib.eu/covid-19/entity/33261658.0>
?:pmid	33261658.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/xpf1utml_HAS_C0029418_PRODUCES_C0079189> <https://research.tib.eu/covid-19/entity/xpf1utml_HAS_C0206131_PRODUCES_C0079189> <https://research.tib.eu/covid-19/entity/xpf1utml_HAS_C0225369_PRODUCES_C0079189> <https://research.tib.eu/covid-19/entity/xpf1utml_HAS_C1720336_TREATS_C0012634>
?:sha_id	<https://research.tib.eu/covid-19/entity/f0919bb8c45a03043d9596e20743712c5ed836dc>
?:source	Medline; PMC
?:title	What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-12-01

Property

Value

?:abstract

BACKGROUND: Human umbilical cord mesenchymal stem cells (HUC-MSCs) present in the umbilical cord tissue are self-renewing and multipotent. They can renew themselves continuously and, under certain conditions, differentiate into one or more cell types constituting human tissues and organs. HUC-MSCs differentiate, among others, into osteoblasts, chondrocytes, and adipocytes and have the ability to secrete cytokines. The possibility of noninvasive harvesting and low immunogenicity of HUC-MSCs give them a unique advantage in clinical applications. In recent years, HUC-MSCs have been widely used in clinical practice, and some progress has been made in their use for therapeutic purposes. MAIN BODY: This article describes two aspects of the clinical therapeutic effects of HUC-MSCs. On the one hand, it explains the benefits and mechanisms of HUC-MSC treatment in various diseases. On the other hand, it summarizes the results of basic research on HUC-MSCs related to clinical applications. The first part of this review highlights several functions of HUC-MSCs that are critical for their therapeutic properties: differentiation into terminal cells, immune regulation, paracrine effects, anti-inflammatory effects, anti-fibrotic effects, and regulating non-coding RNA. These characteristics of HUC-MSCs are discussed in the context of diabetes and its complications, liver disease, systemic lupus erythematosus, arthritis, brain injury and cerebrovascular diseases, heart diseases, spinal cord injury, respiratory diseases, viral infections, and other diseases. The second part emphasizes the need to establish an HUC-MSC cell bank, discusses tumorigenicity of HUC-MSCs and the characteristics of different in vitro generations of these cells in the treatment of diseases, and provides technical and theoretical support for the clinical applications of HUC-MSCs. CONCLUSION: HUC-MSCs can treat a variety of diseases clinically and have achieved good therapeutic effects, and the development of HUC-MSC assistive technology has laid the foundation for its clinical application.

is ?:annotates of